Centers for Disease Control and Prevention | Centers for Disease Control and Prevention |
---|---|
Interim clinical considerations for use of mRNA COVID-19 vaccines currently authorized in the United States | COVID-19 vaccines and allergic reactions |
Centers for Disease Control and Prevention.
1Vaccine adverse event reporting system VAERS | Use of Pfizer-BioNTech COVID-19 vaccine: Clinical considerations |
---|---|
V-safe after vaccination health checker | Centers for Disease Control and Prevention |
Centers for Disease Control and Prevention.
26Centers for Disease Control and Prevention | Centers for Disease Control and Prevention |
---|---|
When vaccine is limited, who should get vaccinated first? Centers for Disease Control and Prevention |
Centers for Disease Control and Prevention.